News >

Challenges Remain, But Research Abounds in Polycythemia Vera and Myelofibrosis

Ellie Leick
Published: Tuesday, Sep 03, 2019

David S. Snyder, MD

David S. Snyder, MD
Treatment options for patients with polycythemia vera (PV) and myelofibrosis have remained stagnant within the past few years, but there have been novel agents moving through the pipeline, explained David S. Snyder, MD, adding that there is uncertainty whether any of them will replace the role of transplant.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication